Your browser doesn't support javascript.
loading
A case report of photodermatoses induced by the antifungal drug terbinafine.
Bacle, Astrid; Belaz, Sorya; Potin, Sophie; Gangneux, Jean-Pierre.
Affiliation
  • Bacle A; Service Hospitalo-Universitaire de Pharmacie, Centre Hospitalier Universitaire de Rennes, Rennes, France.
  • Belaz S; Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, Univ Rennes, CHU Rennes, F-35000 Rennes, France.
  • Potin S; Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, Univ Rennes, CHU Rennes, F-35000 Rennes, France.
  • Gangneux JP; Laboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Rennes, Rennes, France.
Eur J Hosp Pharm ; 26(5): 288-289, 2019 Sep.
Article in En | MEDLINE | ID: mdl-31656618
ABSTRACT
Terbinafine is an antifungaldrug(inhibitor of ergosterol synthesis) known to induce skin reactions. A 58-year-old female was treated with terbinafine for onychomycosis. On the fifth day of treatment a skin rash emerged on her sun-exposed areas. Biological testing did not find any allergic signs. Other skin reactions are well known with terbinafine, but we depict here, a case of photosensitisation induced by treatment, generally unknown for this antifungal. This side effect can be prevented by medication reconciliation and pharmaceutical advice from the clinical pharmacist.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Eur J Hosp Pharm Year: 2019 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Eur J Hosp Pharm Year: 2019 Type: Article Affiliation country: France